By  on January 17, 2018

It has been almost three years since Dr. Fredric Brandt, once called the Baron of Botox, was found dead in an apparent suicide. Under the leadership of Stephane Colleu, Dr. Brandt Skin Care continues to build upon the groundwork established by its founder by building a cadre of experts to continue the vision.

“Our story is very unique because of the situation we had to face, despite having a unique concept being one of the first doctor skin-care lines [Dr. Brandt debuted in 1996],” Colleu, the president and chief executive officer of the company, told WWD. Beyond losing the brand’s mastermind, the company also faced mounting physician brand competition. But thanks in part to tapping the expertise of a Skin Advisory Board, Colleu said the company’s volume is expanding on target. Since Brandt’s death, Colleu reported more than a 40 percent growth rate. “We had our best year ever,” he said of 2017. Industry sources estimated current sales approaching $80 million on the path to $150 million by 2020. The privately held company did not discuss estimates.

To continue reading this article...

load comments
blog comments powered by Disqus